Poole Angela C, Thomas Ruth E, Andrews Laurie A, McBride Heidi M, Whitworth Alexander J, Pallanck Leo J
Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1638-43. doi: 10.1073/pnas.0709336105. Epub 2008 Jan 29.
Loss-of-function mutations in the PTEN-induced kinase 1 (PINK1) or parkin genes, which encode a mitochondrially localized serine/threonine kinase and a ubiquitin-protein ligase, respectively, result in recessive familial forms of Parkinsonism. Genetic studies in Drosophila indicate that PINK1 acts upstream of Parkin in a common pathway that influences mitochondrial integrity in a subset of tissues, including flight muscle and dopaminergic neurons. The mechanism by which PINK1 and Parkin influence mitochondrial integrity is currently unknown, although mutations in the PINK1 and parkin genes result in enlarged or swollen mitochondria, suggesting a possible regulatory role for the PINK1/Parkin pathway in mitochondrial morphology. To address this hypothesis, we examined the influence of genetic alterations affecting the machinery that governs mitochondrial morphology on the PINK1 and parkin mutant phenotypes. We report that heterozygous loss-of-function mutations of drp1, which encodes a key mitochondrial fission-promoting component, are largely lethal in a PINK1 or parkin mutant background. Conversely, the flight muscle degeneration and mitochondrial morphological alterations that result from mutations in PINK1 and parkin are strongly suppressed by increased drp1 gene dosage and by heterozygous loss-of-function mutations affecting the mitochondrial fusion-promoting factors OPA1 and Mfn2. Finally, we find that an eye phenotype associated with increased PINK1/Parkin pathway activity is suppressed by perturbations that reduce mitochondrial fission and enhanced by perturbations that reduce mitochondrial fusion. Our studies suggest that the PINK1/Parkin pathway promotes mitochondrial fission and that the loss of mitochondrial and tissue integrity in PINK1 and parkin mutants derives from reduced mitochondrial fission.
PTEN诱导激酶1(PINK1)或帕金森蛋白基因中的功能丧失突变分别导致隐性家族性帕金森病,这两种基因分别编码一种定位于线粒体的丝氨酸/苏氨酸激酶和一种泛素蛋白连接酶。果蝇的遗传学研究表明,PINK1在一条共同途径中位于帕金森蛋白的上游,该途径影响包括飞行肌和多巴胺能神经元在内的一部分组织中的线粒体完整性。尽管PINK1和帕金森蛋白基因的突变会导致线粒体增大或肿胀,提示PINK1/帕金森蛋白途径在线粒体形态方面可能具有调节作用,但目前尚不清楚PINK1和帕金森蛋白影响线粒体完整性的机制。为了验证这一假说,我们研究了影响线粒体形态调控机制的基因改变对PINK1和帕金森蛋白突变体表型的影响。我们发现,编码关键线粒体分裂促进成分的drp1基因杂合功能丧失突变在PINK1或帕金森蛋白突变背景下大多是致死的。相反,PINK1和帕金森蛋白突变导致的飞行肌退化和线粒体形态改变被drp1基因剂量增加以及影响线粒体融合促进因子OPA1和Mfn2的杂合功能丧失突变强烈抑制。最后,我们发现与PINK1/帕金森蛋白途径活性增加相关的眼表型被减少线粒体分裂的扰动所抑制,并被减少线粒体融合的扰动所增强。我们的研究表明,PINK1/帕金森蛋白途径促进线粒体分裂,并且PINK1和帕金森蛋白突变体中线粒体和组织完整性的丧失源于线粒体分裂减少。